Gene therapy methods and cell growth and cell transplant devices for use therein

• US 20070004035A1
• Filed: 06/30/2005
• Published: 01/04/2007
• Est. Priority Date: 06/30/2005
• Status: Abandoned Application

• Current Assignee: Bioartis Incorporated
• Original Assignee: Bioartis Incorporated
• Inventors: Sitzmann, James
• Application Number:
  US11/171,637
• Publication Number:
  US 20070004035A1
• Time in Patent Office: Days
• US Class Current: 435/325
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/3843 Connective tissue
• CPC Class Codes: C12N 2502/094 keratinocytes
• CPC Class Codes: C12N 2502/1323 Adult fibroblasts
• CPC Class Codes: C12N 5/0697 Artificial constructs associating cells of different lineages, e.g. tissue equivalents blood vessels C12N5/0691
• CPC Class Codes: C12N 5/0698 Skin equivalents

Abstract

An artificial tendon, ligament, bone and skin panel are provided, made of biocompatible materials and capable of being seeded and eventually coated with selected cell types. Seeded or coated artificial tendon, ligament, bone or skin panels can be shaped and implanted in mammals. Implantable cell growth cages may be seeded with selected cell types and used to produce desired gene expression products within a mammal. Gene expression products may be harvested from transfected animal cells cultured in a cell growth chamber.

Claims

1. An artificial connective tissue, comprising:

a plurality of elongated fibers each having a first end and a second end;

a first end fiber at said first end of said elongated fibers; and

a second end fiber at said second end of said elongated fibers,

wherein said first and said second end fibers connect said respective first and second ends of said elongated fibers.

2. An artificial connective tissue according to claim 1, further comprising at least one cross-connecting fiber attached to at least two of said elongated fibers between said first ends and said second ends.

3. An artificial connective tissue according to claim 1, further comprising a layer of fibroblast or tendon cells on said elongated fibers.

4. An artificial weight-bearing bone, comprising:

a plurality of elongated members;

a plurality of circular fibers; and

at least one layer of bone or cartilage cells on at least one of said elongated members,

wherein said elongated members form a generally cylindrical structure,

wherein said circular fibers are located around and permanently attached to said elongated members, and

wherein said circular fibers are spaced along the length of said elongated members.

5. An artificial weight-bearing bone according to claim 4, wherein said elongated members are comprised of metal.

6. An artificial weight-bearing bone according to claim 4, wherein the artificial weight-bearing bone is selected from the group consisting of:

artificial femur, artificial tibia, artificial fibula, artificial rib, artificial clavicle, artificial humerus, artificial radius and artificial ulna.

7. An artificial weight-bearing bone according to claim 4, wherein the artificial weight-bearing bone mimics the shape of a naturally occurring bone or portion thereof.

8. An artificial weight-bearing bone, comprising:

a plurality of elongated members;

a plurality of circular fibers; and

at least one layer of bone or cartilage cells on at least one of said elongated members,

wherein said elongated members form a structure that mimics the shape of a natural bone or portion thereof, and

wherein each of said circular fibers are located around and permanently attached to at least two of said elongated members.

9. An artificial weight-bearing bone according to claim 8, wherein said elongated members are comprised of metal.

10. An artificial weight-bearing bone according to claim 8, wherein the artificial weight-bearing bone is selected from the group consisting of:

artificial scapula, artificial vertebra, artificial inferior maxillary, artificial sternum, artificial patella and artificial os innominatum.

11. An artificial non weight-bearing bone, comprising:

at least one artificial bone scaffold; and

at least one layer of bone or cartilage cells on said artificial bone scaffold,

wherein said artificial bone scaffold is configured to mimic the shape of a natural bone or a portion thereof.

12. An artificial non weight-bearing bone according to claim 11, further comprising a layer of cell growth matrix located along the inner or outer surface of said artificial bone scaffold.

13. An artificial non weight-bearing bone according to claim 11, wherein said artificial non weight-bearing bone is selected from the group consisting of:

artificial nose and artificial ear.

14. An artificial skin panel, comprising:

a fibrous matrix; and

at least one cellular coating on said fibrous matrix,

wherein said at least one cellular coating is comprised of cells selected from the group consisting of superficial cutaneous cells and deep cutaneous cells.

15. An artificial cell growth cage, comprising:

a fibrous matrix; and

a plurality of cells on and within said fibrous matrix,

wherein said cells are capable of producing a desired gene expression product.

16. An artificial cell growth cage according to claim 15, wherein the artificial cell growth cage is tube shaped.

17. An artificial cell growth cage according to claim 16, wherein the artificial cell growth cage has an outer diameter of 10-16 gauge and an inner diameter of 0.5-0.05 mm.

18. An artificial cell growth cage according to claim 15, wherein the artificial cell growth cage is disk shaped.

19. An artificial cell growth cage according to claim 18, wherein the artificial cell growth cage has an outer diameter of 1-3 cm, a length of 3-6 cm and a width of 25-100 mm.

20. A cellular growth chamber, comprising:

a vessel;

an opening in said vessel that allows insertion and removal of a plurality of porous inner tubes and that is sealingly closeable; and

a sealable port providing a opening in said vessel and allowing inlet and outlet of cell culture solution.

21. A method of obtaining a substance, comprising:

culturing cells in a cellular growth chamber according to claim 20;

and

isolating a substance produced by said cells.

22. An isolated substance obtained according to claim 21, wherein the substance is selected from the group consisting of:

myostatin and follistatin.